Jo Whelan. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useAntineoplastic Agents, Phytogenic/administration & dosageAntineoplastic Agents, Phytogenic/therapeutic useBridged-Ring Compounds/administration & dosageBridged-Ring Compounds/therapeutic useDocosahexaenoic AcidsHumansNeoplasms/drug therapyNeoplasms/metabolismPaclitaxel/administration & dosagePaclitaxel/therapeutic usePolyglutamic AcidProdrugsTaxoids
Substances: See more » Antineoplastic AgentsAntineoplastic Agents, PhytogenicBridged-Ring CompoundsProdrugsTaxoidstaxaneDocosahexaenoic AcidsPolyglutamic AcidPaclitaxel
Year: 2002 PMID: 11790612 DOI: 10.1016/s1359-6446(01)02149-3
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851